Overview

Resveratrol in Healthy Adult Participants

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Resveratrol may prevent cancer in healthy people. Studying samples of blood and urine in the laboratory from participants who are taking resveratrol may help doctors learn more about how this drug is used by the body. This phase I trial is studying the side effects of resveratrol and to see how it works in healthy adult participants.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Resveratrol